Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Simvastatin/sitagliptin> ?p ?o. }
Showing items 1 to 38 of
38
with 100 items per page.
- sitagliptin abstract "Simvastatin/sitagliptin is a fixed-dose combination drug consisting of sitagliptin and simvastatin. Sitagliptin is a dipeptidyl peptidase-4 inhibitor used to treat type 2 diabetes and simvastatin is an HMG-CoA reductase inhibitor used to treat hypercholesterolemia. These two disorders commonly occur in patients at the same time, and have been typically treated with administration of these two drugs in separate tablets. The combination was approved in 2011 and is marketed as Juvisync by Merck. Juvisync was later removed from the market in 2013 due to business reasons.".
- sitagliptin wikiPageID "33365420".
- sitagliptin wikiPageRevisionID "605338484".
- sitagliptin class Anti-diabetic_medication.
- sitagliptin class Dipeptidyl_peptidase-4_inhibitor.
- sitagliptin class Hypolipidemic_agent.
- sitagliptin class Statin.
- sitagliptin component "Simvastatin".
- sitagliptin component "Sitagliptin".
- sitagliptin hasPhotoCollection sitagliptin.
- sitagliptin legalUs "Rx-only".
- sitagliptin pregnancyUs "X".
- sitagliptin tradename "Juvisync".
- sitagliptin type "combo".
- sitagliptin verifiedrevid "455022189".
- sitagliptin subject Category:Combination_drugs.
- sitagliptin type Agent114778436.
- sitagliptin type Anti-diabeticDrugs.
- sitagliptin type CausalAgent100007347.
- sitagliptin type Drug103247620.
- sitagliptin type Lipid-loweringMedicine103676175.
- sitagliptin type Matter100020827.
- sitagliptin type Medicine103740161.
- sitagliptin type PhysicalEntity100001930.
- sitagliptin type Statins.
- sitagliptin type Substance100020090.
- sitagliptin type Drug.
- sitagliptin type FunctionalSubstance.
- sitagliptin comment "Simvastatin/sitagliptin is a fixed-dose combination drug consisting of sitagliptin and simvastatin. Sitagliptin is a dipeptidyl peptidase-4 inhibitor used to treat type 2 diabetes and simvastatin is an HMG-CoA reductase inhibitor used to treat hypercholesterolemia. These two disorders commonly occur in patients at the same time, and have been typically treated with administration of these two drugs in separate tablets. The combination was approved in 2011 and is marketed as Juvisync by Merck.".
- sitagliptin label "Associação sinvastatina/sitagliptina".
- sitagliptin label "Simvastatin/sitagliptin".
- sitagliptin sameAs sitagliptina.
- sitagliptin sameAs m.0h7lf_s.
- sitagliptin sameAs Q9635292.
- sitagliptin sameAs Q9635292.
- sitagliptin sameAs sitagliptin.
- sitagliptin wasDerivedFrom sitagliptin?oldid=605338484.
- sitagliptin isPrimaryTopicOf sitagliptin.